Asensus Surgical, Inc. (ASXC)
Aug 22, 2024 - ASXC was delisted (reason: acquired by KARL STORZ)
0.3500
0.00 (0.00%)
Inactive · Last trade price on Aug 21, 2024
Asensus Surgical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|---|---|---|---|---|---|
Net Income | -83.8 | -78.43 | -75.56 | -62.46 | -59.31 | -154.2 |
Depreciation & Amortization | 3.76 | 3.73 | 11.08 | 14.11 | 13.7 | 12.47 |
Other Amortization | - | - | - | - | - | 1.51 |
Loss (Gain) From Sale of Assets | - | - | 0.12 | - | - | -15.87 |
Asset Writedown & Restructuring Costs | 0.37 | 0.37 | 1.43 | - | - | 86.88 |
Loss (Gain) From Sale of Investments | 0.8 | -0.48 | 0.57 | 0.41 | - | -0.33 |
Stock-Based Compensation | 7.3 | 7.92 | 8.42 | 9.43 | 7.91 | 11.51 |
Provision & Write-off of Bad Debts | 0.01 | - | 0.01 | 0.14 | - | 1.63 |
Other Operating Activities | 12.24 | 0.19 | -0.18 | -2.7 | -1.29 | -4.23 |
Change in Accounts Receivable | 0.22 | -1.18 | -1.53 | 0.17 | -0.45 | 6.08 |
Change in Inventory | 0.72 | 0.13 | -2.3 | -0.61 | -4.16 | -16.4 |
Change in Accounts Payable | -2.43 | 0.57 | 0.04 | 1.61 | -1.76 | -0.67 |
Change in Unearned Revenue | 0.39 | 0.23 | -0.06 | -0.23 | -0.11 | -0.96 |
Change in Other Net Operating Assets | 3.78 | 3.32 | -0.97 | -0.54 | -1.21 | -0.91 |
Operating Cash Flow | -56.65 | -63.63 | -58.94 | -40.66 | -46.68 | -73.48 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -0.51 | -0.56 | -1.28 | -1.37 | -0 | -0.44 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 15.97 |
Investment in Securities | 31.6 | 65.07 | 48.82 | -118.3 | - | 52.12 |
Investing Cash Flow | 31.09 | 64.51 | 47.54 | -119.67 | -0 | 67.65 |
Long-Term Debt Issued | - | - | - | - | 2.82 | - |
Long-Term Debt Repaid | - | - | - | - | - | -31.43 |
Net Debt Issued (Repaid) | 15 | - | - | - | 2.82 | -31.43 |
Issuance of Common Stock | 10.9 | 10.12 | 0.02 | 162.77 | 50.67 | 26.32 |
Repurchase of Common Stock | -0.18 | -0.5 | -0.35 | -1.06 | -0.04 | -0.5 |
Other Financing Activities | 0.09 | - | - | - | -0.07 | - |
Financing Cash Flow | 25.81 | 9.63 | -0.33 | 161.71 | 53.37 | -5.61 |
Foreign Exchange Rate Adjustments | 0.02 | 0.76 | -0.08 | 0.38 | 0.27 | 0.36 |
Net Cash Flow | 0.27 | 11.27 | -11.81 | 1.75 | 6.96 | -11.08 |
Free Cash Flow | -57.16 | -64.19 | -60.22 | -42.03 | -46.68 | -73.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -580.27% | -748.37% | -849.67% | -510.53% | -1470.17% | -866.50% |
Free Cash Flow Per Share | -0.22 | -0.26 | -0.25 | -0.19 | -0.66 | -4.17 |
Levered Free Cash Flow | -1.87 | -34.74 | -30.14 | -15.88 | -16.62 | -29.45 |
Unlevered Free Cash Flow | -1.67 | -34.74 | -29.88 | -15.65 | -16.61 | -28.71 |
Cash Interest Paid | - | - | - | - | - | 2.19 |
Cash Income Tax Paid | 0.47 | 0.35 | 0.17 | 0.17 | 0.08 | 0.08 |